ATE299179T1 - Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung - Google Patents

Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung

Info

Publication number
ATE299179T1
ATE299179T1 AT99902219T AT99902219T ATE299179T1 AT E299179 T1 ATE299179 T1 AT E299179T1 AT 99902219 T AT99902219 T AT 99902219T AT 99902219 T AT99902219 T AT 99902219T AT E299179 T1 ATE299179 T1 AT E299179T1
Authority
AT
Austria
Prior art keywords
suppressor trna
oligonucleotides
methods
human suppressor
human
Prior art date
Application number
AT99902219T
Other languages
English (en)
Inventor
Rekha G Panchal
Charles J Link Jr
Original Assignee
Human Gene Therapy Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Gene Therapy Res Inst filed Critical Human Gene Therapy Res Inst
Application granted granted Critical
Publication of ATE299179T1 publication Critical patent/ATE299179T1/de

Links

Classifications

    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04B—TRANSMISSION
    • H04B10/00—Transmission systems employing electromagnetic waves other than radio-waves, e.g. infrared, visible or ultraviolet light, or employing corpuscular radiation, e.g. quantum communication
    • H04B10/25—Arrangements specific to fibre transmission
    • H04B10/2589—Bidirectional transmission
    • H04B10/25891—Transmission components
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/028—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a herpesvirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Electromagnetism (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Signal Processing (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
AT99902219T 1998-01-14 1999-01-13 Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung ATE299179T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7141698P 1998-01-14 1998-01-14
PCT/US1999/000717 WO1999036519A1 (en) 1998-01-14 1999-01-13 HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Publications (1)

Publication Number Publication Date
ATE299179T1 true ATE299179T1 (de) 2005-07-15

Family

ID=22101183

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99902219T ATE299179T1 (de) 1998-01-14 1999-01-13 Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung

Country Status (9)

Country Link
US (2) US6309830B1 (de)
EP (1) EP1045902B1 (de)
JP (1) JP2002508959A (de)
AT (1) ATE299179T1 (de)
AU (1) AU2225199A (de)
CA (1) CA2318374C (de)
DE (1) DE69926052T2 (de)
HK (1) HK1033955A1 (de)
WO (1) WO1999036519A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999036519A1 (en) * 1998-01-14 1999-07-22 Human Gene Therapy Research Institute HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME
WO2000011154A1 (en) * 1998-08-20 2000-03-02 Cell Genesys, Inc. USE OF SUPPRESSOR tRNA'S TO REGULATE CYTOTOXICITY DURING THE PRODUCTION OF RECOMBINANT GENE PRODUCTS
US6964859B2 (en) * 2001-10-16 2005-11-15 Massachusetts Institute Of Technology Suppressor tRNA system
US20050261210A1 (en) * 2004-02-19 2005-11-24 Bhatnagar Rajiv S Nonsense suppressor agents in treatment of cutaneous and gastrointestinal disorders
US20080207538A1 (en) * 2004-03-11 2008-08-28 Lawrence David S Enhanced Production of Functional Proteins From Defective Genes
US7598040B2 (en) * 2006-11-22 2009-10-06 Trana Discovery, Inc. Compositions and methods for the identification of inhibitors of protein synthesis
CA2699370A1 (en) * 2007-09-14 2009-03-19 Trana Discovery Compositions and methods for the identification of inhibitors of retroviral infection
WO2010036795A2 (en) * 2008-09-29 2010-04-01 Trana Discovery, Inc. Screening methods for identifying specific staphylococcus aureus inhibitors
CN107177592B (zh) 2016-03-10 2021-03-30 北京大学 抑制性tRNA通读提前终止密码子疾病中的截短蛋白
US11932856B2 (en) 2017-03-03 2024-03-19 The Regents Of The University Of California RNA targeting of mutations via suppressor tRNAs and deaminases
MX2020004647A (es) 2017-11-02 2021-03-25 Wistar Inst Métodos de rescate de codones de detención por medio de reasignación genética con arn de transferencia editado anti-codones (ace-trna).
US10905778B2 (en) 2018-09-26 2021-02-02 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
AU2019350869A1 (en) * 2018-09-26 2021-05-20 Case Western Reserve University Methods and compositions for treating a premature stop codon-mediated disorder
CA3136430A1 (en) * 2019-04-11 2020-10-15 Arcturus Therapeutics, Inc. Synthetic transfer rna with extended anticodon loop
LU101182B1 (en) * 2019-04-11 2020-10-12 Univ Hamburg Synthetic transfer RNA with extended anticodon loop
CN115038789A (zh) 2019-12-02 2022-09-09 塑造治疗公司 治疗性编辑
WO2022125531A1 (en) * 2020-12-07 2022-06-16 President And Fellows Of Harvard College Methods for making and using genomically recoded cells
WO2023147348A1 (en) * 2022-01-25 2023-08-03 Hc Bioscience, Inc. Universal suppressor trnas and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687737A (en) 1982-11-12 1987-08-18 Massachusetts Institute Of Technology Mammalian suppressor genes
US4970155A (en) * 1983-03-07 1990-11-13 Abbott Laboratories HSV helper virus independent vector
US6111095A (en) * 1995-06-07 2000-08-29 Merck & Co., Inc. Capped synthetic RNA, analogs, and aptamers
WO1999036519A1 (en) * 1998-01-14 1999-07-22 Human Gene Therapy Research Institute HUMAN SUPPRESSOR tRNA OLIGONUCLEOTIDES AND METHODS OF USE FOR SAME

Also Published As

Publication number Publication date
CA2318374A1 (en) 1999-07-22
AU2225199A (en) 1999-08-02
EP1045902B1 (de) 2005-07-06
CA2318374C (en) 2012-09-04
EP1045902A1 (de) 2000-10-25
US7029665B2 (en) 2006-04-18
DE69926052D1 (de) 2005-08-11
US20020156042A1 (en) 2002-10-24
DE69926052T2 (de) 2006-04-27
JP2002508959A (ja) 2002-03-26
HK1033955A1 (en) 2001-10-05
US6309830B1 (en) 2001-10-30
WO1999036519A1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
ATE299179T1 (de) Menschliche suppressor trna oligonukleotide und verfahren für deren verwendung
HK1048831A1 (en) Human ctla-4 antibodies and their uses
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NO20004803L (no) Smilagening og anzurogenin for behandling av Alzheimers sykdom
WO2003013437A3 (en) Compositions and methods for the prevention and treatment of huntington's disease
EP2444809A3 (de) Verfahren zur Herstellung und zum Screening von Proteasen mit veränderter Spezifizität
ATE309196T1 (de) Verfahren zur herstellung von 3-aryloxy-3- arylpropylamine und deren zwischenprodukte
DE69525736T2 (de) Oligonukleotid und kanzerostatisches mittel das dieses als aktiven inhaltstoff enthält
PT1053313E (pt) Oligonucleotidos ''antisense'' optimizados complementares de sequencias de dna metiltransferase
HK1046287A1 (en) Ibd-associated microbial antigens and methods of using same
DE69619114T2 (de) Pyrolopyrimidine und verfahren zu ihrer herstellung
MXPA05005398A (es) Meta para terapia de deterioro cognitivo.
ZA984463B (en) Fused dihydropyrans
WO2003089608A3 (en) Drg11-responsive (dragon) gene family
DE60044247D1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
DE69837267D1 (de) Kcnq kaliumkanäle und verfahren zur deren modulierung
ATE465261T1 (de) Integrin-gekoppelte kinase, ihre hemmstoffe und deren gebrauch für verfahren zur therapeutischen behandlung; gentherapie und bereitstellung von hemmstoffen, die als pseudosubstrate wirken
DK0906443T3 (da) Generering af replikerende molekyler in vivo
TR200200278T2 (tr) Kalsilitik bileşimler
EP1019092A4 (de) Therapeutische und diagnostische mittel für krankheiten mit gestörter glukose-toleranz
ID23184A (id) Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi
DE60134408D1 (de) Für akzessorische hiv proteine kodierende dna impfstoffe
AU4037299A (en) Genetically-modified fibroblasts and the use thereof
WO2000000161A3 (en) Methods for identification of tef-3 interacting factors
TR199802295A2 (xx) Canlı dokular için boya terkibi, imalat prosesi ve displazik dokunun belirlenmesi için kullanım yöntemleri.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties